Shares in Genoptix Inc., a Carlsbad-based biotech, had risen by 56 percent late in the day Oct. 30, the first day the shares traded on the open market.
The Genoptix initial public offering was priced at $17 per share. Late in the trading day Oct. 30, those shares were selling for $26.59. The company’s Nasdaq symbol is GXDX.
Genoptix offers diagnostic services to hematologists and oncologists. Tina Nova is the company’s president, chief executive officer and founder.
The public offering consisted of 5 million shares. The company offered 4,285,714 shares, while certain selling shareholders offered 714,286 shares.
Underwriters were Lehman Bros. Inc., Banc of America Securities LLC and Cowen and Co. LLC. The underwriters have an option to purchase up to 750,000 shares of the stock.
, Brad Graves
